Publications

Veenstra-VanderWeele Lab

Selected Publications

Muller, C.L., Anacker, A.M.J., Rogers, T.D., Goeden, N., Keller, E.H., Forsberg, C.G., … Veenstra-VanderWeele, J. (2017). Impact of maternal serotonin transporter genotype on placental serotonin, fetal forebrain serotonin, and neurodevelopment. Neuropsychopharmacology, 42(2), 427–436. doi: 10.1038/npp.2016.166.

Anagnostou, E., Aman, M.G., Handen, B.L., Sanders, K.B., Shui, A., Hollway, J.A., … Veenstra-VanderWeele, J. (2016). Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial. JAMA Psychiatry, 73(9), 928–937. doi: 10.1001/jamapsychiatry.2016.123

Muller, C.L., Anacker, A.M.J., & Veenstra-VanderWeele, J. (2016). The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience, 321, 24–41. doi: 10.1016/j.neuroscience.2015.11.010

Veenstra-VanderWeele, J., & Warren, Z. (2015). Intervention in the context of development: pathways toward new treatments. Neuropsychopharmacology, 40, 225–237.

Erickson, C.A., Veenstra-VanderWeele, J., Melmed, R.D., McCracken, J.T., Ginsberg, L., Sikich, L., … King, B.H. (2014). STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study. Journal of Autism and Developmental Disorders, 44, 958–964.

Dove, D., Warren, Z., Taylor, J.L., Sathe, N., McPheeters, M.L., & Veenstra-VanderWeele, J. (2012). Medication treatments for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, 130, 717–726.

Hammock, E.A., Veenstra-VanderWeele, J., Yan, Z., Kerr, T.M., Morris, M., Anderson, G.M., … Jacob, S. (2012). Examining autism spectrum disorders by biomarkers: Example from the oxytocin and serotonin systems. Journal of the American Academy of Child and Adolescent Psychiatry, 51, 712–721.

Veenstra-VanderWeele, J., Muller, C.L., Iwamoto, H., Sauer, J.E., Owens, W.A., Cohen, J., … Blakely, R.D. (2012). Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment, and repetitive behavior. Proceedings of the National Academy of Sciences USA, 109, 5469–5474..

For a list of all publications, refer to the National Center for Biotechnology Information.